News | Breast Imaging | April 02, 2024

ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection

ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection

Getty Images


April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced commercial availability of ProFound Cloud. The innovative Software-as-a-Service (SaaS) platform provides medical providers with a cost-effective, secure, and scalable means to access and deploy the latest ProFound Breast Health Suite of AI solutions.

“With the commercial launch of ProFound Cloud, iCAD is enabling interoperability and access to Breast AI Solutions at enterprise scale, revolutionizing global access to cutting-edge AI solutions in breast health,” said Dana Brown, president, and CEO of iCAD. “Through the power of the cloud and our partnership with Google, we empower medical providers to enhance patient outcomes by helping detect cancer earlier.”

Powered by Google Cloud architecture and Google’s Health AI innovations, ProFound Cloud integrates a lightweight edge client and cloud-based components. Together, they securely transport and process mammography screening data between imaging sources, such as imaging modalities and Picture Archive and Communications Systems (PACS) and the cloud-based AI. The processed data is seamlessly delivered to systems that utilize AI outputs, including mammography review workstations, PACS and image and data storage systems.

“The healthcare landscape is shifting towards technology-as-a-service models, avoiding the pitfalls of investing in rapidly outdated hardware and software,” continued Brown. “As AI relies heavily on specialized hardware like graphical processing units (GPUs), setting up and upgrading both software and hardware becomes increasingly complex. Cloud-based solutions, like ProFound Cloud, address this challenge by providing Software as a Service (SaaS) to ensure that all customers access the latest technology without the initial hardware investment, support contracts, and constant updates. Moreover, ProFound Cloud provides facility administrators the ability to access the administration site, enabling them to update configurations and perform administrative tasks in multiple languages.”

“ProFound Cloud represents a significant advancement in the field of radiology, providing a seamless and standardized solution for accessing the latest AI technologies for our imaging network,” remarked Matt Dewey, chief information officer at Wake Radiology, a ProFound Cloud early access beta-testing facility. “This platform will undoubtedly streamline our workflow and improve our ability to deliver high-quality care while increasing volumes to our patient community across The Triangle region of North Carolina.”

“ProFound Cloud is a prime example of how collaboration in healthcare technology drives innovation,” said Shweta Maniar, global director of Life Science Strategy & Solutions, Google Cloud. “By offering AI solutions in a scalable cloud environment, iCAD empowers healthcare providers to deliver earlier, more accurate diagnoses, potentially improving outcomes for countless patients.”

ProFound Cloud is designed to support patients, providers and partners while facilitating the management of diverse data types critical for comprehensive healthcare analysis. This includes 2D and 3D mammography images alongside all cancer images, in parallel, it stores limited images of benign, recall and normal cases. ProFound Cloud also manages ProFound Risk and Density assessment results, radiology and pathology reports and detection results, while ensuring seamless access to critical diagnostic information. Importantly, ProFound Cloud securely handles de-identified patient information and provider data, adhering to strict privacy and compliance standards. The comprehensive approach enables robust analytics for informed decision-making.

For more information: www.icadmed.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now